Skip to Content

GILEAD 4331 300 (Viread 300 mg)

Generic Name: tenofovir

Pill imprint GILEAD 4331 300 has been identified as Viread 300 mg.

Viread is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Viread 300 mg GILEAD 4331 300
Viread 300 mg GILEAD 4331 300
Viread 300 mg GILEAD 4331 300
Generic Name:
GILEAD 4331 300
300 mg
17.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Gilead Sciences
National Drug Code (NDC):
Inactive Ingredients:
corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
FD&C Blue No. 2
aluminum oxide
titanium dioxide
hypromellose 2910 (15000 mPa.s)

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5334 A-S Medication Solutions, LLC (repackager)
54868-4669 Physicians Total Care Inc (repackager)
35356-0073 Lake Erie Medical and Surgical Supply (repackager)
68258-1971 Dispensing Solutions Inc. (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.